Teaching the lungs to tolerate allergens with tiny early exposures
Mechanisms of Antigen-Induced Tolerance in the Lung
['FUNDING_R01'] · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · NIH-11309611
Tiny, early exposures to common allergens are being explored as a way to teach the lungs not to overreact, potentially preventing allergic asthma in newborns and people at risk.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PITTSBURGH AT PITTSBURGH (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-11309611 on ClinicalTrials.gov |
What this research studies
Researchers use newborn mouse models exposed to very small amounts of house dust mite allergen to mimic early-life exposure and watch how tolerance develops. They focus on lung immune cells called dendritic cells and measure gene activity with single-cell RNA sequencing to identify which cells change. To test whether mitochondrial hydrogen peroxide is important, the team uses transgenic mice that deplete mitochondrial H2O2 and compares their responses to normal mice. These experiments aim to reveal molecular signals that could guide safer ways to prevent allergic disease in children.
Who could benefit from this research
Good fit: Families with infants at high risk of allergic disease and people interested in future prevention trials for allergic asthma would be the likely candidates.
Not a fit: People with long-standing severe asthma or allergies caused by non-airborne triggers may not see direct benefit from this research.
Why it matters
Potential benefit: If successful, this work could point to safer ways to prevent allergic asthma by promoting early-life lung tolerance to common allergens.
How similar studies have performed: Allergen immunotherapy has helped several allergic conditions and animal studies support early-life tolerance, but applying similar approaches safely to prevent human asthma is still unproven.
Where this research is happening
PITTSBURGH, UNITED STATES
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RAY, ANURADHA — UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- Study coordinator: RAY, ANURADHA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Allergic Disease